Skip to content
Search

Latest Stories

DHSC issues coronavirus guidance for adult social care sector

Department of Health and Social Care (DHSC) on Friday launched a new guidance for adult social care to better protect the most vulnerable against the coronavirus (COVID-19).

The guidance issued to councils and care providers aims to ensure older people and those with pre-existing conditions and care needs who receive support are best protected against the virus.


As elderly people and those with underlying health conditions are considered more vulnerable to the virus, the advise sets out who should visit those in care and what to do if a positive case is identified or if someone displays symptoms.

The guidance follows a change in government’s coronavirus strategy to the so-called ‘delay’ phase, aimed at putting off the peak until the summer months, ending a phase of outright containment.

“Public safety is my top priority and we are clear people in care should follow the same tried and tested protocols everyone else is following,” Health Secretary Matt Hancock said. “These include good hand hygiene and self-isolating where necessary, allowing our fantastic care workforce to keep them well.”

Hancock said the government is working closely with the social care sector to ensure prompt action to protect those in care.

Councils are entrusted to map out all care and support plans to prioritise people who are at the highest risk and contact all registered providers in their local area to facilitate plans for mutual aid.

“Councils’ adult social care teams are a vital part of how, as a nation, we can best respond to the challenges posed by COVID-19. In such a fast-moving environment, timely guidance and advice is essential and this latest publication will help answer and clarify some of the questions councils and their provider partners have,” said Cllr Ian Hudspeth, Chairman of the Local Government Association’s Community Wellbeing Board.

As of 9am on Friday today, 32,771 people have been tested in the UK for the virus, of which 798 were confirmed as positive. The death toll climbed to 11 as Scotland reported its first fatality later in the day.

Care Minister Helen Whately said: “We recognise that we are entering an incredibly challenging time for people living and working in care and we are working closely with industry experts to do everything we can to limit the impact that COVID-19 has on the most vulnerable.”

“This guidance is an important part of that work. Its aim is to help the NHS, local government and care providers to work together to take the best steps to protect those most at risk.”

DHSC said it will continually review the guidance as the government’s action plan develops, adding that it will issue further guidance to help protect elderly and vulnerable groups.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less